Look Up > Drugs > Praziquantel
Praziquantel
Pronunciation
U.S. Brand Names
Generic Available
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms
References

Pronunciation
(pray zi KWON tel)

U.S. Brand Names
Biltricide®

Generic Available

No


Pharmacological Index

Anthelmintic


Use

All stages of schistosomiasis caused by all Schistosoma species pathogenic to humans; clonorchiasis and opisthorchiasis


Pregnancy Risk Factor

B


Contraindications

Ocular cysticercosis, known hypersensitivity to praziquantel


Warnings/Precautions

Use caution in patients with severe hepatic disease; patients with cerebral cysticercosis require hospitalization


Adverse Reactions

1% to 10%:

Central nervous system: Dizziness, drowsiness, headache, malaise

Gastrointestinal: Abdominal pain, loss of appetite, nausea, vomiting

Miscellaneous: Diaphoresis

<1%: CSF reaction syndrome in patients being treated for neurocysticercosis, fever, rash, urticaria, itching, diarrhea


Overdosage/Toxicology

Symptoms of overdose include dizziness, drowsiness, headache, liver function impairment

Treatment is supportive following GI decontamination; administer fast-acting laxative


Drug Interactions

Hydantoins may decrease praziquantel levels causing treatment failures


Mechanism of Action

Increases the cell permeability to calcium in schistosomes, causing strong contractions and paralysis of worm musculature leading to detachment of suckers from the blood vessel walls and to dislodgment


Pharmacodynamics/Kinetics

Absorption: Oral: ~80%; CSF concentration is 14% to 20% of plasma concentration

Distribution: CSF concentration is 14% to 20% of plasma concentration; appears in breast milk

Protein binding: ~80%

Metabolism: Extensive first-pass metabolism

Half-life: Parent drug: 0.8-1.5 hours; Metabolites: 4.5 hours

Time to peak serum concentration: Within 1-3 hours

Elimination: Urinary excretion (99% as metabolites)


Usual Dosage

Children >4 years and Adults: Oral:

Flukes: 25 mg/kg/dose every 8 hours for 1-2 days

Cysticercosis: 50 mg/kg/day divided every 8 hours for 14 days

Tapeworms: 10-20 mg/kg as a single dose (25 mg/kg for Hymenolepis nana)

Clonorchiasis/opisthorchiasis: 3 doses of 25 mg/kg as a 1-day treatment


Mental Health: Effects on Mental Status

May cause dizziness or drowsiness


Mental Health: Effects on Psychiatric Treatment

None reported


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

Take exactly as directed for full course of medication. Tablets may be chewed, swallowed whole, or crushed and mixed with food. Increase dietary intake of fruit juices. All family members and close friends should also be treated. To reduce possibility of reinfection, wash hands and scrub nails carefully with soap and hot water before handling food, before eating, and before and after toileting. Keep hands out of mouth. Disinfect toilet daily and launder bed lines, undergarments, and nightclothes daily with hot water and soap. Do not go barefoot and do not sit directly on grass or ground. May cause dizziness, fainting, lightheadedness (use caution when driving or engaging in tasks that require alertness until response to drug is known); abdominal pain, nausea, or vomiting (frequent small meals, frequent mouth care, sucking lozenges, or chewing gum may help). Report unusual fatigue, persistent dizziness, CNS changes, change in color of urine or stool, or easy bruising or unusual bleeding.


Nursing Implications

Tablets can be halved or quartered


Dosage Forms

Tablet, tri-scored: 600 mg


References

de Silva N, Guyatt H, and Bundy D, "Anthelmintics. A Comparative Review of Their Clinical Pharmacology," Drugs, 1997, 53(5):769-88.

"Drugs for Parasitic Infections," Med Lett Drugs Ther, 1998, 40(1017):1-12.

King CH and Mahmoud AA, "Drug Five Years Later: Praziquantel," Ann Intern Med, 1989, 110(4):290-6.

Liu LX and Weller PF, "Antiparasitic Drug," N Engl J Med, 1996, 334(18):1178-84.


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved